Monterey Bio Acquisition (MTRYU) Stock Analysis

What Monterey Bio Acquisition does

Monterey Bio Acquisition Corporation, founded in New York, New York, in 2020, does not currently have significant business operations. Its sole purpose is to identify and complete a business combination, such as a merger, acquisition, or stock exchange, with one or more companies in the biotechnology sector. The firm officially changed its name to Monterey Bio Acquisition Corporation in April 2021, having previously been known as Chardan FinTech Acquisition Corp.

Key metrics

ETFs linked to MTRYU

Broad-market and Financial Services sector ETFs an investor holding Monterey Bio Acquisition is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MTRYU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Monterey Bio Acquisition?

Monterey Bio Acquisition trades under the ticker MTRYU on NASDAQ.

Which exchange is MTRYU listed on?

MTRYU is listed on NASDAQ.

What sector does Monterey Bio Acquisition operate in?

Monterey Bio Acquisition is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze MTRYU in a portfolio?

PortView shows MTRYU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.